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Abstract 
In this talk I will summarize our recent and ongoing work analysing large 
pharmaco-genomic screenings in cancer, that provide rich information about 
alterations in tumours that confer drug sensitivity or resistance. Integration of 
this data with prior knowledge on signaling pathways and transcription factors 
provides biomarkers and offer hypotheses for novel combination therapies. 
Multi-task learning combining these features and drugs’ information leads to 
further insights into drug efficacy. I will also describe the insights gained when 
addressing this problem in a crowdsourced manner, by posing a challenge to 
the scientific community. This was performed in the context of the DREAM 
Challenges, and I will present this initiative and its infrastructure by means of 
containerized model submissions, that allows us to use sensitive data for the 
challenges. An important message from the challenge and our own results is 
that that prediction of drug efficacy is far from accurate, implying important 
limitations for personalised medicine. An arguably under-appreciated aspect 
that deserves further attention is the dynamics of signaling networks and how 
they response to perturbations such as drug treatment. I will show how cell-
specific logic models, trained with measurements upon perturbations, can 
provides new biomarkers and treatment opportunities not noticeable by static 
molecular characterisation. Finally, I will show how, using novel microfluidics-
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His group develops and applies computational methods to acquire a functional 
understanding of signaling networks and their deregulation in disease, and to 
apply this knowledge to develop novel therapeutics. To this end, his group 
collaborates closely with experimental groups and pharmaceutical companies. 
More information at www.Sáezlab.org. 
